HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Are Cosmetic Endocrine-Disruptor Checks Sufficient? EU Commission Issues Long-Awaited Position

This article was originally published in The Rose Sheet

Executive Summary

Industry no doubt welcomes the Commission’s long-overdue review of the European Cosmetics Regulation as it pertains to chemicals with endocrine-disrupting properties. The report concludes that the existing regulatory framework is adequate to evaluate and manage suspected endocrine disruptors, while putting stakeholders on notice that a number of prioritized ingredients will be up for review in 2019.   


Related Content

EU’s SCCS Reissues Guidance On Cosmetic Ingredient Testing With Updated Non-Animal Method Perspectives
EU Watch: Next Steps Re Controversial CMR Ban Approach, Fragrance Allergens Labeling
EU Endocrine Disruptor Guidance Open For Comments; Benefit Cosmetics Recall; More News In Brief
EC Releases Endocrine-Disruptor Criteria, Drawing Heavily On WHO Definitions
Europe Bans Preservative Mixture MCI/MI In Leave-On Cosmetics





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts